CavalierChem acquired an unprofitable surfactant manufacturing facility. Analysis reveals the facility has identical costs to its competitor but charges lower prices (5.67 vs 7.67 cents/lb on contracts), resulting in 4x lower profits. Candidates must recommend whether to increase pricing, repurpose the facility for other products, or divest it entirely.
Key Insights:
- Cost parity with competitors does not guarantee equal profitability—pricing power and market positioning are critical value drivers
- Framework thinking: Structure the problem across three dimensions (improve current business, repurpose, divest) before diving into detailed analysis
- Quantification: Converting pricing differences into incremental profit ($42M) makes the business case compelling and actionable
- Risk consideration: Higher pricing may reduce market share or customer acceptance, requiring validation of customer willingness-to-pay
- Sunk cost fallacy: Acquisition price should not influence forward-looking strategic decisions